PMID- 32282647 OWN - NLM STAT- MEDLINE DCOM- 20210914 LR - 20210914 IS - 1539-2864 (Electronic) IS - 0275-004X (Linking) VI - 41 IP - 1 DP - 2021 Jan 1 TI - EPIDEMIOLOGY OF VITREOMACULAR INTERFACE ABNORMALITIES USING MACULAR SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN AN ELDERLY POPULATION (THE MONTRACHET STUDY). PG - 60-67 LID - 10.1097/IAE.0000000000002802 [doi] AB - PURPOSE: The aim of this study was to investigate the prevalence of vitreomacular interface abnormalities (VMIAs) and to identify associated factors in an elderly population in Europe. METHODS: The MONTRACHET (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases) Study is a population-based study, conducted in subjects older than 75 years. Vitreomacular adhesions, vitreomacular tractions, macular holes, epiretinal membranes, and macular cysts were assessed on spectral-domain optical coherence tomography examinations. The prevalence of VMIAs was estimated. We studied the association of demographic and clinical factors with VMIAs. RESULTS: The mean age of the participants was 82.3 (SD, 3.8) years, and 37.3% were men. The prevalence rates of VMIAs were vitreomacular adhesions (17.7%), vitreomacular tractions (1.4%), lamellar macular holes (1.0%), full-thickness macular holes (0.2%), macular pseudoholes (0.4%), epiretinal membranes (38.9%), and macular cysts (5.8%). In multivariate analysis, vitreomacular adhesions were positively associated with male sex (P < 0.001) and negatively associated with older age (P < 0.001) and cataract extraction (P < 0.001). Epiretinal membranes were positively associated with older age (P < 0.001) and cataract extraction (P < 0.001). CONCLUSION: The prevalence of VMIAs based on spectral-domain optical coherence tomography analysis was high in subjects older than 75 years. FAU - Ben Ghezala, Ines AU - Ben Ghezala I AD - Ophthalmology Department, Dijon-Bourgogne University Hospital, Dijon, France. AD - Clinical Epidemiology Unit, Inserm, CIC 1432, Dijon, France. FAU - Seydou, Alassane AU - Seydou A AD - Clinical Epidemiology Unit, Inserm, CIC 1432, Dijon, France. AD - Clinical Epidemiology/Clinical Trials Unit, Dijon-Bourgogne University Hospital, Clinical Investigation Center, Dijon, France. FAU - Gabrielle, Pierre-Henry AU - Gabrielle PH AD - Ophthalmology Department, Dijon-Bourgogne University Hospital, Dijon, France. AD - Clinical Epidemiology/Clinical Trials Unit, Dijon-Bourgogne University Hospital, Clinical Investigation Center, Dijon, France. FAU - Bouche-Pillon, Jacques AU - Bouche-Pillon J AD - Ophthalmology Department, Dijon-Bourgogne University Hospital, Dijon, France. FAU - Binquet, Christine AU - Binquet C AD - Clinical Epidemiology Unit, Inserm, CIC 1432, Dijon, France. FAU - Delcourt, Cecile AU - Delcourt C AD - Eye and Nutrition Group, Centre des Sciences du Gout et de l'Alimentation, CNRS, INRAe, University Bourgogne Franche-Comte, Dijon, France. FAU - Daien, Vincent AU - Daien V AD - Bordeaux Population Health Research Center, University of Bordeaux, Inserm, Team LEHA, UMR 1219, Bordeaux, France. AD - Department of Ophthalmology, Gui de Chauliac Hospital, Montpellier, France; and. FAU - Bron, Alain M AU - Bron AM AD - Ophthalmology Department, Dijon-Bourgogne University Hospital, Dijon, France. AD - Clinical Epidemiology/Clinical Trials Unit, Dijon-Bourgogne University Hospital, Clinical Investigation Center, Dijon, France. FAU - Creuzot-Garcher, Catherine AU - Creuzot-Garcher C AD - Ophthalmology Department, Dijon-Bourgogne University Hospital, Dijon, France. AD - Clinical Epidemiology/Clinical Trials Unit, Dijon-Bourgogne University Hospital, Clinical Investigation Center, Dijon, France. LA - eng PT - Journal Article PT - Multicenter Study PL - United States TA - Retina JT - Retina (Philadelphia, Pa.) JID - 8309919 SB - IM MH - Aged MH - Aged, 80 and over MH - Female MH - France/epidemiology MH - Humans MH - Male MH - *Population Surveillance MH - Prevalence MH - Retinal Diseases/diagnosis/*epidemiology MH - Tomography, Optical Coherence/*methods MH - *Visual Acuity MH - Vitreous Body/*pathology EDAT- 2020/04/14 06:00 MHDA- 2021/09/15 06:00 CRDT- 2020/04/14 06:00 PHST- 2020/04/14 06:00 [pubmed] PHST- 2021/09/15 06:00 [medline] PHST- 2020/04/14 06:00 [entrez] AID - 00006982-202101000-00007 [pii] AID - 10.1097/IAE.0000000000002802 [doi] PST - ppublish SO - Retina. 2021 Jan 1;41(1):60-67. doi: 10.1097/IAE.0000000000002802.